Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$793M |
| 2 |
Microsoft
MSFT
|
+$777M |
| 3 |
Coca-Cola
KO
|
+$755M |
| 4 |
Apple
AAPL
|
+$744M |
| 5 |
NVIDIA
NVDA
|
+$718M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Real Estate ETF
VNQ
|
+$251M |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$247M |
| 3 |
Oracle
ORCL
|
+$228M |
| 4 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$176M |
| 5 |
MRO
Marathon Oil Corporation
MRO
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.59% |
| 2 | Financials | 12.77% |
| 3 | Consumer Discretionary | 9.88% |
| 4 | Healthcare | 9.85% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Tompkins Financial
TMP
$1.45B
| $9.22M | ﹤0.01% |
135,886
-12,540
| -8% | -$869K |
|
|
RWT
2052
Redwood Trust
RWT
$580M
| $9.21M | ﹤0.01% |
1,411,153
-196,990
| -12% | -$1.42M |
|
|
PYCR
2053
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $9.2M | ﹤0.01% |
495,259
+6,480
| +1% | +$108K |
|
2054
Vir Biotechnology
VIR
$1.5B
| $9.19M | ﹤0.01% |
1,252,655
+118,379
| +10% | +$934K |
|
2055
Dole
DOLE
$1.36B
| $9.18M | ﹤0.01% |
678,203
-297,083
| -30% | -$4.56M |
|
2056
Intellia Therapeutics
NTLA
$1.5B
| $9.18M | ﹤0.01% |
787,490
-40,055
| -5% | -$625K |
|
2057
Matthews International
MATW
$876M
| $9.18M | ﹤0.01% |
331,717
-34,175
| -9% | -$876K |
|
2058
iShares Core S&P US Growth ETF
IUSG
$32.7B
| $9.14M | ﹤0.01% |
65,614
-27,029
| -29% | -$3.71M |
|
2059
AdvanSix
ASIX
$542M
| $9.08M | ﹤0.01% |
318,813
-59,343
| -16% | -$1.79M |
|
2060
Middlesex Water
MSEX
$1.07B
| $9.08M | ﹤0.01% |
172,472
+5,191
| +3% | +$326K |
|
2061
Ducommun
DCO
$2.76B
| $9.08M | ﹤0.01% |
142,572
-15,889
| -10% | -$1.02M |
|
2062
Sphere Entertainment
SPHR
$5.29B
| $9.04M | ﹤0.01% |
224,282
+4,490
| +2% | +$188K |
|
2063
Utz Brands
UTZ
$1.25B
| $9.03M | ﹤0.01% |
576,730
+5,569
| +1% | +$94.1K |
|
2064
HCI Group
HCI
$2.29B
| $9.02M | ﹤0.01% |
77,391
+3,815
| +5% | +$435K |
|
2065
Universal Technical Institute
UTI
$2.28B
| $9.01M | ﹤0.01% |
350,630
+4,858
| +1% | +$101K |
|
2066
BioLife Solutions
BLFS
$1.57B
| $8.99M | ﹤0.01% |
346,421
+26,462
| +8% | +$658K |
|
|
OKLO
2067
Oklo
OKLO
$7.17B
| $8.97M | ﹤0.01% |
422,431
-22
| -0% | -$426 |
|
2068
NextNav
NN
$1.81B
| $8.97M | ﹤0.01% |
576,254
+29,448
| +5% | +$392K |
|
2069
Calumet Specialty Products
CLMT
$3.69B
| $8.93M | ﹤0.01% |
405,697
+4,496
| +1% | +$94.5K |
|
2070
Sprinklr
CXM
$1.53B
| $8.92M | ﹤0.01% |
1,055,292
+18,021
| +2% | +$144K |
|
2071
Astec Industries
ASTE
$1.21B
| $8.9M | ﹤0.01% |
264,950
-43,931
| -14% | -$1.52M |
|
2072
Spyre Therapeutics
SYRE
$8.24B
| $8.84M | ﹤0.01% |
379,650
+46,375
| +14% | +$1.36M |
|
2073
AngloGold Ashanti
AU
$41.3B
| $8.81M | ﹤0.01% |
381,627
+122,507
| +47% | +$3.2M |
|
2074
Ironwood Pharmaceuticals
IRWD
$728M
| $8.79M | ﹤0.01% |
1,983,240
+78,969
| +4% | +$320K |
|
2075
Hudbay
HBM
$10.4B
| $8.78M | ﹤0.01% |
1,083,298
-43,643
| -4% | -$391K |
|
Similar funds
Charles Schwab's Q4 2024 Portfolio in Review
As of Q4 2024, Charles Schwab held 3,563 positions worth $542B, up 3.5% from $524B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Charles Schwab deployed $17.7B of net new capital in Q4 2024, opening 62 new positions and adding to 2,296 existing holdings. Its largest new stake was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard Mortgage-Backed Securities ETF, an estimated $247M trimmed.
- Charles Schwab's largest Q4 2024 buy was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.
- Charles Schwab added most to Amgen in Q4 2024, an estimated $793M increase.
- Charles Schwab's biggest Q4 2024 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $247M.
- Charles Schwab fully exited Vanguard Real Estate ETF in Q4 2024, selling an estimated $251M.
- Charles Schwab's ten largest holdings make up 23% of its $542B portfolio in Q4 2024.
- Charles Schwab opened 62 new positions and closed 70 in Q4 2024.
- Charles Schwab's portfolio value rose 3.5% quarter-over-quarter to $542B.
Based on Charles Schwab's 13F filing for Q4 2024, filed 6 Feb 2025.